Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+१.७६%
१,११४.१४
+१९.३०
+१.७६%
—१,०९४.८४१,१०७.९११,११९.४२१,१०७.९१——
SIXC
Communications
SIXC
Communications
SIXC
+१.५५%
६१३.६०
+९.३९
+१.५५%
—६०४.२१६०४.२१६१४.७३६०४.२१——
SIXE
Energy
SIXE
Energy
SIXE
-४.०९%
१,१९८.५६
-५१.१५
-४.०९%
—१,२४९.७११,२१९.४६१,२१९.४६१,१९१.३४——
SIXI
Industrials
SIXI
Industrials
SIXI
+२.६०%
१,७८४.४५
+४५.१९
+२.६०%
—१,७३९.२६१,७५४.१११,७८८.८७१,७५४.११——
SIXM
Financials
SIXM
Financials
SIXM
+०.५०%
६३८.७९
+३.१६
+०.५०%
—६३५.६३६३७.४६६४३.४२६३७.४६——
SIXR
Staples
SIXR
Staples
SIXR
+०.२६%
८५०.५०
+२.१८
+०.२६%
—८४८.३२८५०.९०८५३.०५८४६.६८——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+१.३५%
२१९.६९
+२.९३
+१.३५%
—२१६.७६२१६.७६२२०.४३२१६.७६——
SIXT
Technology
SIXT
Technology
SIXT
+२.६७%
३,४२४.१९
+८९.०५
+२.६७%
—३,३३५.१४३,३७६.१३३,४२५.५२३,३६०.२९——
SIXU
Utilities
SIXU
Utilities
SIXU
-१.४५%
९२५.७६
-१३.५८
-१.४५%
—९३९.३४९३७.३२९३७.५९९२४.४८——
SIXV
Health care
SIXV
Health care
SIXV
+०.०८%
१,४६९.४०
+१.२३
+०.०८%
—१,४६८.१७१,४६८.९८१,४७६.५०१,४६४.१४——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+१.५७%
२,४२४.६२
+३७.५३
+१.५७%
—२,३८७.०९२,३९४.१८२,४३६.८०२,३९४.१८——
ALNOV:EPA
Novacyt SA
€ ०.३४
+१.६३%
(+०.००५५) 1D
मे ६, १७:३६:३२ GMT+२  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ALNOV...
Open
€ ०.३४
High
€ ०.३६
Low
€ ०.३२
Mkt. cap
२.६३ करोड
Avg. vol.
१.४५ लाख
Volume
३.८८ लाख
52-wk high
€ ०.७४
52-wk low
€ ०.२९
EPS
-€ ०.५०
Shares outstanding
७.२६ करोड
No. of employees
२३४
News stories
From sources across the web
TipRanks
TipRanks
·
१ दिन पहिले
Novacyt Updates Market on Liquidity Agreement Trades and Voting Rights
Investegate
Investegate
·
१ दिन पहिले
Liquidity Agreement Monthly Update and TVR
Profile
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare. In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
About Novacyt SA
CEODavid Allmond
Employees२३४
Founded२००६ जुलाई ३
Headquarters-
Sector-
Websitenovacyt.com
Previous reports
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in GBP
२०२४ सेप्टेम्बर
२०२४ डिसेम्बर
२०२५ मार्च
२०२५ जुन
Revenue
-
-
४८.९६ लाख
४८.९६ लाख
Cost of goods sold
-
-
१६.४३ लाख
१६.४३ लाख
Cost of revenue
-
-
१६.४३ लाख
१६.४३ लाख
Research and development expenses
-
-
१०.२२ लाख
१०.२२ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
५५.०८ लाख
५५.०८ लाख
Operating expense
-
-
६४.३२ लाख
६४.३२ लाख
Total operating expenses
-
-
८०.७५ लाख
८०.७५ लाख
Operating income
-
-
-३१.७८ लाख
-३१.७८ लाख
Other non operating income
-
-
-३१.०० हजार
-३१.०० हजार
EBT including unusual items
-
-
-३५.१३ लाख
-३५.१३ लाख
EBT excluding unusual items
-
-
-३१.२० लाख
-३१.२० लाख
Income tax expense
-
-
-१.३४ लाख
-१.३४ लाख
Effective tax rate
-
-
३.८०%
३.८०%
Other operating expenses
-
-
-९७.५० हजार
-९७.५० हजार
Net income
-
-
-३१.७१ लाख
-३१.७१ लाख
Net profit margin
-
-
-६४.७६%
-६४.७६%
Earnings per share
-
-
-
-
Interest and investment income
-
-
१.७७ लाख
१.७७ लाख
Interest expense
-
-
-१.५४ लाख
-१.५४ लाख
Net interest expenses
-
-
२३.०० हजार
२३.०० हजार
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-२१.६६ लाख
-२१.६६ लाख
Gain or loss from assets sale
-
-
-१.४८ लाख
-१.४८ लाख
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer